Dadashi et al demonstrated that a combination of metformin and digoxin-loaded nanoparticles exerted synergistic anticancer effects in MCF-7 breast cancer cells through the downregulation of critical oncogenic pathways, notably NOTCH-1 and HIF-1α gene expression (19). The gene discussed is HIF1A; the disease is breast cancer.